Department of Pediatrics, Kyorin University School of Medicine, Mitaka, Tokyo, 181-8611, Japan.
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Mitaka, Tokyo, 181-8611, Japan.
Biochem Biophys Res Commun. 2022 Jul 23;614:198-206. doi: 10.1016/j.bbrc.2022.05.043. Epub 2022 May 14.
Podocyte damage is a major pathological lesion leading to focal segmental glomerulosclerosis (FSGS). Podocytes damaged by cellular stress undergo hypertrophy to compensate for podocytopenia. It is known that cyclin-dependent kinase inhibitors induced by p53 ensure podocytes hypertrophy; however, its precise mechanism remains to be further investigated. In this study, we found that ubiquitin specific protease 40 (USP40) is a novel regulator of p53. Although USP40 knockout mice established in the present study revealed no abnormal kidney phenotype, intermediate filament Nestin was upregulated in the glomeruli, and was bound to and colocalized with USP40. We also found that USP40 deubiquitinated histidine triad nucleotide-binding protein 1 (HINT1), an inducer of p53. Gene knockdown experiments of USP40 in cultured podocytes revealed the reduction of HINT1 and p53 protein expression. Finally, in glomerular podocytes of mouse FSGS, upregulation of HINT1 occurred in advance of the proteinuria, which was followed by upregulation of USP40, p53 and Nestin. In conclusion, USP40 bound to Nestin deubiquitinates HINT1, and in consequence upregulates p53. These results provide additional insight into the pathological mechanism of podocyte hypertrophy in FSGS.
足细胞损伤是导致局灶节段性肾小球硬化症(FSGS)的主要病理病变。受细胞应激损伤的足细胞发生肥大以代偿足细胞减少症。已知 p53 诱导的细胞周期蛋白依赖性激酶抑制剂可确保足细胞肥大;然而,其确切的机制仍有待进一步研究。在这项研究中,我们发现泛素特异性蛋白酶 40(USP40)是 p53 的一种新型调节因子。尽管本研究中建立的 USP40 敲除小鼠未显示出异常的肾脏表型,但中间丝巢蛋白在肾小球中上调,并与 USP40 结合并共定位。我们还发现 USP40 去泛素化组氨酸三联核苷酸结合蛋白 1(HINT1),HINT1 是 p53 的诱导剂。在培养的足细胞中进行 USP40 的基因敲低实验表明,HINT1 和 p53 蛋白表达减少。最后,在 FSGS 小鼠的肾小球足细胞中,HINT1 的上调先于蛋白尿,随后 USP40、p53 和巢蛋白上调。总之,USP40 与 Nestin 结合,去泛素化 HINT1,从而上调 p53。这些结果为 FSGS 中足细胞肥大的病理机制提供了更多的见解。